期刊文献+

NT-proBNP对老年患者心力衰竭的评估 被引量:9

Diagnostic values of N-terminal pro-B-type natriuretic peptide in elderly patients with heart failure
原文传递
导出
摘要 心力衰竭(HF)的发病率和病死率逐渐升高,HF的总患病率为2%-3%。NT—proBNP作为生物标志物,已经被证实广泛用于HF患者的诊断,NT—proBNP受多种因素影响,而年龄对其的影响广受关注。结合年龄因素使用NT—proBNP判断老年患者HF至关重要。 The morbidity and mortality of heart failure (I-IF) were gradually increased, around 2% -3% of the population suffered from HF. As a biomarker, NT-proBNP has been shown to be widely used in the diagnosis of HF patients. NT-proBNP lever is affected by many factors, especially the age, age-specific NT-proBNP lever is very important in diagnosis of elderly HF patients.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2012年第10期878-880,共3页 Chinese Journal of Laboratory Medicine
关键词 NT—proBNP 心力衰竭 影响因素 NT-proBNP Heart failure Influencing factors
  • 相关文献

参考文献18

  • 1Hystad ME, Geiran OR, Attramadal H, et al. Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure. Acta Physiol Scand, 2001, 171:395-403.
  • 2Apple FS, Wu AH, Jaffe AS, et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Icaboratory Medicine Practice Guidelines : Analytical Issues for Biomarkers of Heart Failure. Circulation, 2007, 116 : e95-e98.
  • 3Elin RJ, Winter WE. Laboratory and clinical aspects of B-type natriuretic peptides. Arch Pathol Lab Med, 2004, 125:697-699.
  • 4Dickstein K, Cohan-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 :the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J, 2008, 29:2388-2442.
  • 5Januzzi JL Jr, Camargo CA, Anwaruddin S, et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol, 2005, 95:948-954.
  • 6Fuat A, Murphy JJ, Hungin AP, et al. The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure. Br J Gen Pract, 2006, 56:327-333.
  • 7Kelder JC, Cowie MR, McDonagh TA, et al. Quantifying the added value of BNP in suspected heart failure in general practice : an individual patient data meta-analysis. Heart, 2011,97:959-963.
  • 8Kelder JC, Cramer M J, Verweij WM, et al. Clinical utility of three B-type natriuretic peptide assays for the initial diagnostic assessment of new slow-onset heart failure. J Card Fail, 2011, 17:729-734.
  • 9Gustafsson F, Steensgaard-Hansen F, Badskjaer J, et al. Diagnostic and prognostic performance of N-terminal proBNP in primary care patients with suspected heart failure. J Card Fail, 2005, 11 :S15-S20.
  • 10Januzzi JL, van Kimmenade R, Lainehbury J, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients:the International Collaborative of NT-proBNP Study. Eur Heart J, 2006, 27:330-337.

同被引文献60

引证文献9

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部